Halladay Benjamin
Chief Financial Officer · 8 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-13 | ESPR | Esperion Therapeutics, Inc. | D | 705,410 | — | — | filing |
| 2026-06-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 10,773 | $3.16 | $33,988.82 | filing |
| 2026-03-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 6,424 | $2.71 | $17,376.92 | filing |
| 2026-03-13 | ESPR | Esperion Therapeutics, Inc. | Award | 247,430 | $0.00 | $0.00 | filing |
| 2025-12-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 7,337 | $3.67 | $26,904.78 | filing |
| 2025-09-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 7,046 | $2.81 | $19,785.17 | filing |
| 2025-07-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 11 | $1.12 | $12.27 | filing |
| 2025-06-17 | ESPR | Esperion Therapeutics, Inc. | Sale | 7,229 | $1.15 | $8,327.81 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.